Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salvatore Crisafulli

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Recenti Progressi in Medicina|July 19, 2022
[The role of real-world evidence for the study of rare diseases epidemiology and the post-marketing evaluation of orphan drugs.]Salvatore Crisafulli, Gianluca Trifirò
Thorax|September 15, 2023
Is antidepressant use a concern for patients with COPD?Gianluca Trifirò, Salvatore Crisafulli
Clinical Toxicology (Philadelphia, Pa.)|May 29, 2025
Characterizing pharmacobezoar formation: a descriptive analysis from VigiBaseMassimo Carollo, Nicoletta Luxi, Salvatore Crisafulli
BMJ (Clinical Research Ed.)|February 26, 2026
Transparency of post-authorisation studiesJanet Sultana, Salvatore Crisafulli, Gianluca Trifirò
Journal of the American Geriatrics Society|September 6, 2024
Reply to: Deprescribing is associated with reduced readmission to hospital: An updated meta-analysis of randomized controlled trialsAndrea Fontana, Massimo Carollo, Salvatore Crisafulli, et al.
Drug Safety|April 19, 2020
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?Gianluca Trifirò, Salvatore Crisafulli, Giuseppe Andò, et al.
Toxins|July 26, 2024
Understanding Clinical Effectiveness and Safety Implications of Botulinum Toxin in Children: A Narrative Review of the LiteratureSalvatore Crisafulli, Francesco Ciccimarra, Zakir Khan, et al.
Expert Opinion on Drug Safety|May 27, 2023
An overview of methodological flaws of real-world studies investigating drug safety in the post-marketing settingSalvatore Crisafulli, Zakir Khan, Yusuf Karatas, et al.
Brain Sciences|October 28, 2023
Pharmacological Therapies of Spinal Muscular Atrophy: A Narrative Review of Preclinical, Clinical-Experimental, and Real-World EvidenceSalvatore Crisafulli, Brigida Boccanegra, Giacomo Vitturi, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 20, 2020
Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and RisksSalvatore Crisafulli, Valentina Isgrò, Laura La Corte, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Recenti Progressi in Medicina|July 19, 2022
[The role of real-world evidence for the study of rare diseases epidemiology and the post-marketing evaluation of orphan drugs.]Salvatore Crisafulli, Gianluca Trifirò
Thorax|September 15, 2023
Is antidepressant use a concern for patients with COPD?Gianluca Trifirò, Salvatore Crisafulli
Clinical Toxicology (Philadelphia, Pa.)|May 29, 2025
Characterizing pharmacobezoar formation: a descriptive analysis from VigiBaseMassimo Carollo, Nicoletta Luxi, Salvatore Crisafulli
BMJ (Clinical Research Ed.)|February 26, 2026
Transparency of post-authorisation studiesJanet Sultana, Salvatore Crisafulli, Gianluca Trifirò
Journal of the American Geriatrics Society|September 6, 2024
Reply to: Deprescribing is associated with reduced readmission to hospital: An updated meta-analysis of randomized controlled trialsAndrea Fontana, Massimo Carollo, Salvatore Crisafulli, et al.
Drug Safety|April 19, 2020
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?Gianluca Trifirò, Salvatore Crisafulli, Giuseppe Andò, et al.
Toxins|July 26, 2024
Understanding Clinical Effectiveness and Safety Implications of Botulinum Toxin in Children: A Narrative Review of the LiteratureSalvatore Crisafulli, Francesco Ciccimarra, Zakir Khan, et al.
Expert Opinion on Drug Safety|May 27, 2023
An overview of methodological flaws of real-world studies investigating drug safety in the post-marketing settingSalvatore Crisafulli, Zakir Khan, Yusuf Karatas, et al.
Brain Sciences|October 28, 2023
Pharmacological Therapies of Spinal Muscular Atrophy: A Narrative Review of Preclinical, Clinical-Experimental, and Real-World EvidenceSalvatore Crisafulli, Brigida Boccanegra, Giacomo Vitturi, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 20, 2020
Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and RisksSalvatore Crisafulli, Valentina Isgrò, Laura La Corte, et al.
Pageof 6